Deutsch English Français

Contact

EP1292359

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1292359

EP1292359 - SYSTEM AND METHOD FOR ASSESSING THE PERFORMANCE OF A PHARMACEUTICAL AGENT DELIVERY SYSTEM [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 24.08.2007 Database last updated on 03.10.2024
Most recent event Tooltip	24.08.2007	Application deemed to be withdrawn	published on 26.09.2007 [2007/39]
Applicant(s)	For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US
	[N/P]
Former [2003/12]	For all designated states MERCK & CO., INC. 126 East Lincoln Avenue Rahway, New Jersey 07065 / US
Inventor(s)	01 / SIMON, Adam, J. 543 Fawnhill Drive Langhorne, PA 19047 / US
	[2003/12]
Representative(s)	Patentanwälte Ruff, Wilhelm, Beier, Dauster & Partner mbB Kronenstrasse 30 70174 Stuttgart / DE
	[N/P]
Former [2003/12]	Patentanwälte Ruff, Wilhelm, Beier, Dauster & Partner Kronenstrasse 30 70174 Stuttgart / DE
Application number, filing date	01939219.0	22.05.2001
	[2003/12]
	WO2001US16398
Priority number, date	US20000206121P	22.05.2000 Original published format: US 206121 P
	[2003/12]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0189455
	Date:	29.11.2001
	Language:	EN
	[2001/48]
	Type:	A2 Application without search report
	No.:	EP1292359
	Date:	19.03.2003
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 29.11.2001 takes the place of the publication of the European patent application.
	[2003/12]
Search report(s)	International search report - published on:	US	29.08.2002
	(Supplementary) European search report - dispatched on:	EP	04.03.2005
Classification	IPC:	A61N1/32, C25B11/04, H01B1/00, H01M4/66	[2005/01]
	CPC:	A61N1/325 (EP,US); A61K49/0002 (EP,US); A61N1/306 (EP,US)
	Former IPC [2003/21]	A61K9/00
	Former IPC [2003/12]	A61N1/00, A61N1/04, A61N1/18, A61N1/30, A61N1/32, C12M1/42, C12N13/00
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/12]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	SYSTEM UND VERFAHREN ZUR BEWERTUNG DER WIRKSAMKEIT EINES VERABREICHUNGSSYSTEMS FÜR PHARMAZEUTIKA	[2003/12]
	English:	SYSTEM AND METHOD FOR ASSESSING THE PERFORMANCE OF A PHARMACEUTICAL AGENT DELIVERY SYSTEM	[2003/12]
	French:	SYSTEME ET PROCEDE PERMETTANT D'EVALUER L'EFFICACITE D'UN DISPOSITIF D'ADMINISTRATION D'AGENT PHARMACEUTIQUE	[2003/12]
Entry into regional phase	20.12.2002	National basic fee paid
	20.12.2002	Search fee paid
	20.12.2002	Designation fee(s) paid
	20.12.2002	Examination fee paid
Examination procedure	21.12.2001	Request for preliminary examination filed International Preliminary Examining Authority: US
	20.12.2002	Examination requested [2003/12]
	28.09.2006	Despatch of a communication from the examining division (Time limit: M06)
	11.04.2007	Application deemed to be withdrawn, date of legal effect [2007/39]
	11.05.2007	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/39]
Fees paid	Renewal fee
	10.05.2003	Renewal fee patent year 03
	14.05.2004	Renewal fee patent year 04
	19.05.2005	Renewal fee patent year 05
	28.03.2006	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	31.05.2007	07 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]US5515848 (CORBETT III SCOTT S [US], et al) [X] 5-7,11,12,14 * column 3, line 4 - column 13, line 9 *;
		[X]US5911223 (WEAVER JAMES C [US], et al) [X] 5-14 * column 2, line 18 - column 9, line 50 *;
		[A]US5968006 (HOFMANN GUNTER A [US]) [A] 5-14* the whole document *;
		[X]US5983131 (WEAVER JAMES C [US], et al) [X] 5,6,11-14 * column 2, line 20 - column 13, line 4 *
	International search	[X]US5515848 (CORBETT III SCOTT S [US], et al);
		[X]US5983131 (WEAVER JAMES C [US], et al);
		[Y]US5968006 (HOFMANN GUNTER A [US])
		[Y] - OSHIMA ET AL., "Targeted gene transfer to corneal endothelium in vivo by electric pulse", GENE THERAPY, (199810), vol. 5, no. 10, pages 1347 - 1354, XP001029779 DOI: http://dx.doi.org/10.1038/sj.gt.3300725
		[Y] - BUREAU ET AL., "Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer", BIOCHIMICA ET BIOPHYSICA ACTA, (20000501), vol. 1474, no. 3, pages 353 - 359, XP004276575 DOI: http://dx.doi.org/10.1016/S0304-4165(00)00028-3
		[Y] - ZHANG ET AL, "In vivo transdermal delivery of large molecules by pressure-mediated electroincorporation and electroporation: a novel method for drug and gene delivery", BIOELECTROCHEMISTRY AND BIOENERGISTICS, (1997), vol. 42, pages 283 - 292, XP002950932 DOI: http://dx.doi.org/10.1016/S0302-4598(96)05128-8

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p